Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.36 USD | +2.61% | -2.49% | +1.73% |
15/05 | Compugen Names David Silberman CFO | MT |
09/05 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.73% | 93.45M | |
+42.97% | 50.93B | |
-0.38% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.82% | 26.02B | |
-21.87% | 18.9B | |
+7.66% | 13.21B | |
+24.06% | 12.17B | |
+30.18% | 12.16B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Sector Update: Health Care